Chemotherapy before surgery for advanced gallbladder cancer
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests whether giving chemotherapy before surgery helps people with locally advanced gallbladder cancer that can still be removed. It may improve outcomes by shrinking the tumor beforehand.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have gallbladder cancer that is advanced but can still be removed with surgery.
- Your overall health status allows you to be up and active (ECOG score 0-2).
- If you have already had gallbladder removal, there must be signs of leftover disease on scans, or a history of bile spill or piecemeal removal.
- You do not have distant spread (metastasis) or certain major blood vessel involvement.
- You are not pregnant and are willing to follow the study protocol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether receiving chemotherapy (cisplatin, gemcitabine, and nab-paclitaxel) before surgery can improve outcomes for people with high-risk bile duct or gallbladder cancer. It compares this approach to going straight to surgery.
This trial tests a new approach for gallbladder cancer that has grown into nearby areas but hasn't spread far. It combines a drug called AK112 (a type of immunotherapy that helps your immune system fight cancer) with standard chemotherapy and an anti-angiogenesis drug (GAP) before surgery, in the hope of shrinking the tumor enough to allow successful surgery.
This trial tests a combination of two chemotherapy drugs and an immunotherapy drug given before surgery for bile duct cancer. The goal is to see if this approach shrinks tumors and lowers the chance of cancer coming back after surgery.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This trial tests a chemotherapy approach after surgery for bile duct or gallbladder cancers. The goal is to see if giving chemotherapy based on a detailed analysis of your tumor (called 3D-PTA) helps prevent the cancer from coming back.
This trial tests giving chemotherapy before any surgery to people with borderline resectable or locally advanced pancreatic cancer. The goal is to shrink the tumor, which may make surgery more successful and improve outcomes.
Hear when a new Gall Bladder Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.